Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells.
BACKGROUND
Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine (Ser/Thr) kinase comprising two isoforms, GSK-3α and GSK-3β. Both enzymes are similarly inactivated by serine phosphorylation (GSK-3α at Ser21 and GSK-3β at Ser9) and activated by tyrosine phosphorylation (GSK-3α at Tyr279 and GSK-3β at Tyr216). Antibodies raised to phosphopeptides containing the sequences around these phosphorylation sites are frequently used to provide an indication of the activation state of GSK-3 in cell and tissue extracts. These antibodies have further been used to determine the subcellular localisation of active and inactive forms of GSK-3, and the results of those studies support roles for GSK-3 phosphorylation in diverse cellular processes. However, the specificity of these antibodies in immunocytochemistry has not been addressed in any detail.


RESULTS
Taking advantage of gene silencing technology, we examined the specificity of several commercially available anti-phosphorylated GSK-3 antibodies. We show that antibodies raised to peptides containing the phosphorylated Ser21/9 epitope crossreact with unidentified antigens that are highly expressed by mitotic cells and that mainly localise to spindle poles. In addition, two antibodies raised to peptides containing the phosphorylated Tyr279/216 epitope recognise an unidentified protein at focal contacts, and a third antibody recognises a protein found in Ki-67-positive cell nuclei. While the phosphorylated Ser9/21 GSK-3 antibodies also recognise other proteins whose levels increase in mitotic cells in western blots, the phosphorylated Tyr279/216 antibodies appear to be specific in western blotting. However, we cannot rule out the posssibility that they recognise very large or very small proteins that might not be detected using a standard western blotting approach.


CONCLUSIONS
Our findings indicate that care should be taken when examining the subcellular localisation of active or inactive GSK-3 and, furthermore, suggest that the role of GSK-3 phosphorylation in some cellular processes be reassessed.
Cell Biology and Stem Cells Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Bizkaia Technology Park, 48160 Derio, Spain.
Victor M
VM
Campa
Robert M
RM
Kypta
D045163:Antibodies, Phospho-Specific / Q000276:immunology*; D000941:Antigens / Q000276:immunology; D002467:Cell Nucleus / Q000276:immunology; D002477:Cells / Q000201:enzymology*; D004789:Enzyme Activation; D022001:Focal Adhesions / Q000276:immunology; D020868:Gene Silencing; D038362:Glycogen Synthase Kinase 3 / Q000276:immunology*; D000071679:Glycogen Synthase Kinase 3 beta; D049452:Green Fluorescent Proteins / Q000378:metabolism; D007527:Isoenzymes / Q000276:immunology; D008938:Mitosis; D010768:Phosphoserine / Q000276:immunology; D019000:Phosphotyrosine / Q000276:immunology; D010957:Plasmids / Q000235:genetics; D034741:RNA, Small Interfering / Q000378:metabolism
D045163:Antibodies, Phospho-Specific; D000941:Antigens; D007527:Isoenzymes; D034741:RNA, Small Interfering; D049452:Green Fluorescent Proteins; D010768:Phosphoserine; D019000:Phosphotyrosine; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3; C448021:glycogen synthase kinase 3 alpha
Mol Cancer. 2010 Mar 10;9:55
20219091
J Cell Sci. 2003 Apr 1;116(Pt 7):1175-86
12615961
J Immunol. 1998 May 1;160(9):4159-60
9574514
J Biol Chem. 2001 Oct 5;276(40):37436-42
11495916
J Neurochem. 2010 Apr;113(1):117-30
20067585
Oncogene. 2008 Jul 24;27(32):4478-87
18391981
EMBO J. 1993 Feb;12(2):803-8
8382613
Biochem J. 1994 Nov 1;303 ( Pt 3):701-4
7980435
Sci Signal. 2010 May 11;3(121):ra37
20460648
Nature. 1995 Dec 21-28;378(6559):785-9
8524413
Nature. 2000 Jul 6;406(6791):86-90
10894547
Anal Biochem. 1998 Nov 1;264(1):124-7
9784196
Mol Cell Biol. 2006 Feb;26(3):898-911
16428445
Nat Rev Drug Discov. 2004 Jun;3(6):479-87
15173837
Nat Rev Neurosci. 2010 Aug;11(8):539-51
20648061
Dev Cell. 2009 Dec;17(6):788-99
20059949
Biotechniques. 2010 Mar;48(3):197-209
20359301
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1140-5
11805297
Cell. 2001 Jun 15;105(6):721-32
11440715
J Clin Invest. 2008 Nov;118(11):3609-18
18830417
Biol Direct. 2009 Feb 02;4:5
19187541
BMC Cell Biol. 2007 Aug 14;8:34
17697341
J Cell Sci. 2003 Feb 15;116(Pt 4):637-46
12538764
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11074-9
10995469
Mol Biol Cell. 2006 Apr;17(4):1834-44
16452634
Methods Mol Biol. 2008;468:45-65
19099245
J Biol Chem. 2008 Jan 25;283(4):2454-64
18055457
Mol Cell. 2001 Jun;7(6):1321-7
11430833
Genes Dev. 1998 Nov 15;12(22):3499-511
9832503